Browse
Search
Agenda 04-07-2026; 8-a - Minutes for March 5, 2026, March 10, 2026, and March 17, 2026
OrangeCountyNC
>
BOCC Archives
>
Agendas
>
Agendas
>
2026
>
Agenda - 04-07-2026 Business Meeting
>
Agenda 04-07-2026; 8-a - Minutes for March 5, 2026, March 10, 2026, and March 17, 2026
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/2/2026 3:04:25 PM
Creation date
4/2/2026 2:31:49 PM
Metadata
Fields
Template:
BOCC
Date
4/7/2026
Meeting Type
Business
Document Type
Agenda
Agenda Item
8-a
Document Relationships
Agenda for April 7, 2026 BOCC Meeting
(Message)
Path:
\BOCC Archives\Agendas\Agendas\2026\Agenda - 04-07-2026 Business Meeting
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
88
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
25 <br /> 1 Slide #7 <br /> LOSt Containment Strategy Considerations <br /> • RxSaveCard Monthly Surcharge for Spousal <br /> Require use of RxSaveCard for Coverage <br /> coverage of GLP-1 drugs for weight $200 per month surcharge if spouse has <br /> loss alternative coverage available <br /> Direct to consumer approach— Would applyto Employee+Spouse Plan and <br /> prescriptions received from Family Plan <br /> manufacturer by mail <br /> Employee receives$375 monthly 144 spouses currently enrolled in County <br /> health plan. <br /> allowance <br /> Drug costs below$375 per month NCHIP estimates 20%or 29 spouses would <br /> are returned to the County remain on County plan <br /> v$500,000 savings projected based Potential revenue increase to the plan <br /> on continued utilization -$64,000 <br /> May deter spousal migration to County plan <br /> Positive impact on employee costs from other coverage <br /> for most prescriptions <br /> - Avoids increased cost of spousal claims <br /> 2 <br /> 3 <br /> 4 Slide #8 <br /> RxSaveCard provides a direct-to- <br /> consumer relationship with GLP-1 drug <br /> RxSaveCard manufacturers,Lilly Direct and <br /> NovoCare <br /> CURRENTP9M RasaveCard Eliminates cost associated with the <br /> o,,,g Dow Esil lad Employ a oimwPri•a ocsubsidy Employeepharmacy Benefits Manager(PBM) <br /> Insurance Price Monthly nonlhly <br /> Jaftrrehffie) Cml(l anal <br /> Wegovy Cmp all $950 $25 $350 $375 $o <br /> Zephoond(Inj) low $850 s25 $zse $375 $o Wegovy Injectable Example: <br /> Zell(inj) mid ettiso $25 $ass $375 $24 $950 per month=cost to current plan <br /> Zephound(inj) high $W $25 $449 $375 $74 <br /> Wegovy(oral) low W $25 $149 $375 $o $350 per month=cost direct-to- <br /> Wegovyloral) mid $aoo $25 $249 $375 $o consumerplan through RxSaveCard <br /> Wegovy(oral) high $W0 W5 =9 $375 $0 <br /> • $600 per month savings to County plan <br /> Reduces employee costs for most <br /> prescriptions from$25 per month to$0 <br /> with exception of Zepbound Injectable <br /> I <br /> 5 <br /> 6 <br /> 7 <br /> 8 <br /> 9 <br /> 10 <br />
The URL can be used to link to this page
Your browser does not support the video tag.